Reply to ‘Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’’
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.